Orchid Pharma Ltd consolidated Q3FY23 net profit soars to Rs. 7.58 crores

Orchid Pharma Limited has reported Consolidated financial results for the period ended December 31, 2022.

Financial Results (Q3 FY2023) - QoQ Comparison

The company has reported total income of Rs. 168.6913 crores during the period ended December 31, 2022 as compared to Rs. 171.0892 crores during the period ended September 30, 2022.

The company has posted net profit / (loss) of Rs. 7.5869 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. -5.3948 crores for the period ended September 30, 2022.

The company has reported EPS of Rs. 1.86 for the period ended December 31, 2022 as compared to Rs. -1.32 for the period ended September 30, 2022.

Financials	Q3 FY2023	Q2 FY2023	% Change
Total Income	₹168.6913 crs	₹171.0892 crs	-1.40%
Net Profit	₹7.5869 crs	₹-5.3948 crs	240.63%
EPS	₹1.86	₹-1.32	240.91%

Financial Results (Q3 FY2023) - YoY Comparison

The company has reported total income of Rs.168.6913 crores during the period ended December 31, 2022 as compared to Rs.163.7424 crores during the period ended December 31, 2021.

The company has posted net profit / (loss) of Rs.7.5869 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.-13.8632 crores for the period ended December 31, 2021.

The company has reported EPS of Rs.1.86 for the period ended December 31, 2022 as compared to Rs.-3.40 for the period ended December 31, 2021.

Financials	Q3 FY2023	Q3 FY2022	% Change
Total Income	₹168.6913 crs	₹163.7424 crs	3.02%
Net Profit	₹7.5869 crs	₹-13.8632 crs	154.73%
EPS	₹1.86	₹-3.40	154.71%

Financial Results (9 Months Ended FY2023) - YoY Comparison

The company has reported total income of Rs.473.6994 crores during the 9 Months period ended December 31, 2022 as compared to Rs.388.6811 crores during the 9 Months period ended December 31, 2021.

The company has posted net profit / (loss) of Rs.-12.8213 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.4.6352 crores for the 9 Months period ended December 31, 2021.

The company has reported EPS of Rs.-3.14 for the 9 Months period ended December 31, 2022 as compared to Rs.1.14 for the 9 Months period ended December 31, 2021.

Financials	9 Months Ended FY2023	9 Months Ended FY2022	% Change
Total Income	₹473.6994 crs	₹388.6811 crs	21.87%
Net Profit	₹-12.8213 crs	₹4.6352 crs	-376.61%
EPS	₹-3.14	₹1.14	-375.44%

Shares of Orchid Pharma Limited was last trading in BSE at Rs. 386.65 as compared to the previous close of Rs. 388.90. The total number of shares traded during the day was 952 in over 33 trades.

The stock hit an intraday high of Rs. 392.00 and intraday low of 375.00. The net turnover during the day was Rs. 363013.00.

Source : Equity Bulls

Keywords

OrchidPharma Q3FY23 9MFY23 ResultUpdate